argus

Ajanta Pharma Ltd.

NSE: AJANTPHARMINE031B0104943,571 Cr

Timeline

Time (IST)TypeMEventSrc
31 Aug, 11:46 aminvestor_meet1Ajanta Pharma Limited has informed the Exchange about an analysts/institutional investor meet or conference call update.nse
31 Aug, 11:44 amAjanta Pharma Ltd - 532331 - Participation In Investor Conferencebse
27 Aug, 03:31 pmAjanta Pharma Ltd - 532331 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011bse
19 Aug, 05:41 pmAjanta Pharma Ltd - 532331 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.bse
14 Aug, 12:50 pmAjanta Pharma Ltd - 532331 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.bse
05 Aug, 04:57 pmAjanta Pharma Limited has informed the Exchange about Participation in Investor Conferencense
05 Aug, 04:55 pmAjanta Pharma Ltd - 532331 - Participation In Investor Conferencebse
03 Aug, 04:31 pmAjanta Pharma Limited has informed the Exchange about Transcriptnse
03 Aug, 04:27 pmAjanta Pharma Ltd - 532331 - Announcement under Regulation 30 (LODR)-Earnings Call Transcriptbse
30 Jul, 05:40 pmAjanta Pharma Limited has informed the Exchange about Link of Recordingnse
30 Jul, 05:38 pmAjanta Pharma Ltd - 532331 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
30 Jul, 02:54 pmAjanta Pharma Limited has informed the Exchange about ESOP Allotmentnse
30 Jul, 02:42 pmAjanta Pharma Ltd - 532331 - Corporate Action-Board approves Dividendbse
30 Jul, 02:42 pmAjanta Pharma Limited has informed the Exchange that Board of Directors at its meeting held on July 30, 2026, declared Select Dividend of Rs. 32 per equity share.nse
30 Jul, 02:39 pmAjanta Pharma Limited has informed the Exchange that Record date for the purpose of Dividend is 05-Aug-2026.nse
30 Jul, 02:38 pmAjanta Pharma Ltd - 532331 - Results For 30.06.2026bse
30 Jul, 02:35 pmAjanta Pharma Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.nse
30 Jul, 02:35 pmAjanta Pharma Ltd - 532331 - Board Meeting Outcome for BM Outcomebse
29 Jul, 12:23 pmAjanta Pharma Ltd - 532331 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.bse
20 Jul, 10:51 amAjanta Pharma Ltd - 532331 - Update on board meetingbse
20 Jul, 10:43 amAjanta Pharma Ltd - 532331 - Board Meeting Intimation for Board Meeting Scheduled To Be Held On 30Th July 2026.bse
14 Jul, 10:26 amAjanta Pharma Ltd - 532331 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.bse
08 Jul, 02:13 pmAjanta Pharma Ltd - 532331 - Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.bse
03 Jul, 11:12 amAjanta Pharma Ltd - 532331 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011bse
03 Jul, 10:31 amAjanta Pharma Ltd - 532331 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.bse
02 Jul, 01:56 pmAjanta Pharma Limited has informed the Exchange about General Updatesnse
02 Jul, 01:51 pmAjanta Pharma Ltd - 532331 - Update On US FDA Inspection At Paithan Manufacturing Facilitybse
01 Jul, 12:21 pmAjanta Pharma Ltd - 532331 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.bse
27 Jun, 12:44 pmAjanta Pharma Ltd - 532331 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.bse
19 Jun, 02:25 pmAjanta Pharma Ltd - 532331 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.bse
18 Jun, 10:49 amAjanta Pharma Ltd - 532331 - Reg. 34 (1) Annual Report.bse
15 Jun, 11:13 ampledge3Ajanta Pharma promoter/trustee Aayush Agrawal Trust created a pledge on 11,11,111 shares (pledge for new loan) with RBL Bank Ltd, reported on 12-Jun-2026 (pledge creation dated 10-Jun-2026).bse
15 Jun, 09:15 amprocedural0Ajanta Pharma informed the Exchange about its 47th Annual General Meeting scheduled for 16/07/2026.nse
12 Jun, 04:10 pminvestor_meet1Ajanta Pharma Limited informed the exchange about its participation in an investor conference.nse
09 Jun, 03:41 pmshareholding_change1Ajanta Pharma promoter entity (Ravi Agrawal Trust) sold 34,50,000 shares (~2.76% of paid-up equity) of Ajanta Pharma on 9 Jun 2026, reducing promoter shareholding from 13.00% to 10.24% while retaining 57,56,777 shares (~4.61%) under encumbrance.bse
09 Jun, 10:22 ampledge3Ajanta Pharma disclosed creation of pledge on 28,55,925 shares by promoter trustee Aayush Agrawal Trust on 28,55,925 shares for a new loan under SEBI SAST Reg. 31(1) & 31(2) (dated 4 Jun; exchange receipt mentioned 8 Jun 2026).bse
09 Jun, 10:21 ampledge3Gabs Investments Pvt Ltd created a pledge on 27,70,000 Ajanta Pharma shares on 27-Jun-2026 as security for a new loan.bse
02 Jun, 10:29 amAjanta Pharma Ltd - 532331 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.bse
29 May, 01:38 pmAjanta Pharma Ltd - 532331 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.bse
19 May, 05:00 pmAjanta Pharma Limited has informed the Exchange about (Revised) Participation in Investor Conferencense
19 May, 04:56 pmAjanta Pharma Ltd - 532331 - Revised Intimation Of Participation In Investor Conferencebse
19 May, 03:43 pmAjanta Pharma Limited has informed the Exchange about Participation in Investor Conferencense
19 May, 03:40 pmAjanta Pharma Ltd - 532331 - Participation In Investor Conferencebse
13 May, 04:54 pmAjanta Pharma Ltd - 532331 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.bse
12 May, 11:05 amAjanta Pharma Ltd - 532331 - Compliances-Reg.24(A)-Annual Secretarial Compliancebse
08 May, 04:39 pmAjanta Pharma Limited has informed the Exchange about Transcriptnse
08 May, 04:34 pmAjanta Pharma Ltd - 532331 - Announcement under Regulation 30 (LODR)-Earnings Call Transcriptbse
05 May, 06:01 pmAjanta Pharma Limited has informed the Exchange about Link of Recordingnse
05 May, 05:58 pmAjanta Pharma Ltd - 532331 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
05 May, 03:45 pmAjanta Pharma Limited has informed the Exchange about General Updatesnse